Non-small Cell Lung Cancer Study US75 (Z-PACT)

NCT00086268 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Small Cell Lung Carcinoma

Interventions

DRUG: zoledronic acid
DRUG: Taxotere
DRUG: Carboplatin

Sponsor

Novartis Pharmaceuticals